Nonstop Improvements and Nonstop Discoveries
Checkpoint inhibitors and CAR-T immunotherapy are created to stay and succeed and change the way cancer has been treated for decades. The reason is that the successful results from some early attempts to enable the immune system to attack and fight cancers through these new immunotherapy approaches were unmatched in the history of cancer treatments. These successes, though, were only a hint or suggestion that the best is yet to come through finding ways towards improving the efficacy of the new approaches while overcoming the adverse . . .